APPLICATION
ANDA076776
TYPE
ANDA
ORIGINAL APPROVAL
2004-09-16
LATEST ACTION
2024-03-15
ROUTE
BUCCAL
DOSAGE FORM
GUM, CHEWING
MARKETING STATUS
Discontinued
Products
NICOTINE POLACRILEXDiscontinued
NICOTINE POLACRILEX EQ 2MG BASE · GUM, CHEWING · BUCCAL
Approval history
2024-03-15Labeling · Supplement 20 · standardAP
2012-11-29Labeling · Supplement 17 · standardAP
2010-06-17Labeling · Supplement 14AP
2005-08-15Labeling · Supplement 2AP
2005-07-15Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.